Fennec Pharmaceuticals Inc. (FENC)
USD 5.66
(-6.75%)
USD 5.66
(-6.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 21.25 Million | 1.53 Million | - | 170 Thousand | - | - |
| Cost of Revenue | 1.25 Million | 86 Thousand | - | - | - | - |
| Gross Profit | 19.99 Million | 1.44 Million | - | 170 Thousand | - | - |
| Operating Expenses | 32.76 Million | 24.03 Million | 17.22 Million | 18.05 Million | 13 Million | 10.4 Million |
| Selling, General and Administrative Expenses | 32.7 Million | 20.5 Million | 12.24 Million | 12.95 Million | 7.4 Million | 5.4 Million |
| Research and Development Expenses | 56 Thousand | 3.53 Million | 4.98 Million | 5.1 Million | 5.6 Million | 5 Million |
| Other Expenses | - | - | - | -9000.00 | -17 Thousand | 6000.00 |
| Cost and Expenses | 34.02 Million | 24.12 Million | 17.22 Million | 18.05 Million | 13 Million | 10.4 Million |
| Operating Income | -12.77 Million | -22.58 Million | -17.22 Million | -17.88 Million | -13 Million | -10.4 Million |
| Interest Expense | 3.39 Million | 978 Thousand | 126 Thousand | 9000.00 | - | - |
| Income Tax Expense | - | 1.12 Million | 110 Thousand | -187 Thousand | -315 Thousand | -348 Thousand |
| Earnings before Tax | -16.04 Million | -23.71 Million | -17.34 Million | -18.1 Million | -12.77 Million | -9.88 Million |
| Net Income | -16.04 Million | -24.83 Million | -17.45 Million | -17.92 Million | -12.46 Million | -9.88 Million |
| Earnings Per Share Basic | -0.60 | -0.95 | -0.67 | -0.76 | -0.63 | -0.52 |
| Earnings Per Share Diluted | -0.60 | -0.95 | -0.67 | -0.76 | -0.63 | -0.52 |
| Weighted Average Shares Outstanding | 26.57 Million | 26.27 Million | 26 Million | 23.7 Million | 19.89 Million | 18.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.57 Million | 26.27 Million | 26 Million | 23.7 Million | 19.89 Million | 19.01 Million |
| Gross Margin | 0.94 | 0.94 | - | 1.00 | - | - |
| EBIT Margin | -0.58 | -14.69 | - | -105.79 | - | - |
| Profit Margin | -0.75 | -16.18 | - | -105.42 | - | - |
| EBITDA | -12.36 Million | -22.58 Million | -123 Thousand | -17.88 Million | 234 Thousand | 521 Thousand |
| Earnings Before Tax Margin | -0.60 | -14.72 | - | -105.21 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.26 Million | 25.26 Million | 21.64 Million | 10 Million | 6.51 Million | 3.32 Million |
| Cost of Revenue | 607.87 Thousand | 547.54 Thousand | 1.28 Million | 703.93 Thousand | 331 Thousand | 148 Thousand |
| Gross Profit | 6.65 Million | 24.71 Million | 20.35 Million | 9.3 Million | 6.18 Million | 3.17 Million |
| Operating Expenses | 11.69 Million | 11.03 Million | 33.36 Million | 11.16 Million | 7.27 Million | 7.91 Million |
| Selling, General and Administrative Expenses | 11.53 Million | 11.03 Million | - | 11.13 Million | 7.18 Million | 7.83 Million |
| Research and Development Expenses | 156.96 Thousand | 2986.60 | - | 32.88 Thousand | 12 Thousand | 8000.00 |
| Other Expenses | - | - | - | -72 Thousand | - | - |
| Cost and Expenses | 12.29 Million | 11.58 Million | 34.64 Million | 11.87 Million | 7.6 Million | 8.06 Million |
| Operating Income | -5.03 Million | 13.68 Million | -13 Million | -1.86 Million | -1.01 Million | -4.66 Million |
| Interest Expense | 1.04 Million | 1.03 Million | 3.39 Million | 915 Thousand | 856 Thousand | 825 Thousand |
| Income Tax Expense | 1043.00 | -723 Thousand | 1.00 | 1.00 | 856 Thousand | 825 Thousand |
| Earnings before Tax | -5.55 Million | 12.77 Million | -16.33 Million | -2.75 Million | -1.86 Million | -5.44 Million |
| Net Income | -5.55 Million | 12.83 Million | -16.33 Million | -2.75 Million | -1.86 Million | -5.44 Million |
| Earnings Per Share Basic | -0.20 | 0.47 | - | -0.10 | -0.07 | -0.21 |
| Earnings Per Share Diluted | -0.20 | 0.41 | - | -0.10 | -0.07 | -0.21 |
| Weighted Average Shares Outstanding | 27.29 Million | 27.04 Million | 26.57 Million | 26.83 Million | 26.59 Million | 26.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.29 Million | 31.09 Million | 26.57 Million | 26.83 Million | 26.59 Million | 26.45 Million |
| Gross Margin | 0.92 | 0.98 | 0.94 | 0.93 | 0.95 | 0.96 |
| EBIT Margin | -0.69 | 0.54 | - | -0.19 | -0.14 | -1.37 |
| Profit Margin | -0.76 | 0.51 | -0.75 | -0.28 | -0.29 | -1.64 |
| EBITDA | -5.03 Million | 13.68 Million | - | -1.86 Million | -915 Thousand | -4.55 Million |
| Earnings Before Tax Margin | -0.69 | 0.54 | -0.60 | -0.19 | -0.16 | -1.40 |
CCNTF
601699
NEA
BRY
TSL
VALIANTLAB